Literature DB >> 29911321

Fractional carbon dioxide laser resurfacing of skin grafts: long-term results of a prospective, randomized, split-scar, evaluator-blinded study.

Elisabeth Datz1, Carmen Schönberger1,2, Florian Zeman3, Michael Koller3, Mark Berneburg1, Michael Landthaler1, Sigrid Karrer1, Ulrich Hohenleutner1, Silvia Hohenleutner1.   

Abstract

BACKGROUND: Fractional ablative resurfacing is frequently used for treating atrophic and acne scars as well as for the early improvement of scars after surgery. No evidence-based clinical data on improving the appearance of skin grafts by fractional CO2 -laser resurfacing have been available so far.
OBJECTIVES: The primary outcome parameter was the adaptation of the skin graft to the surrounding skin 2, 6, and 12 months after the second laser treatment. Secondary outcome parameters were melanin variation, skin roughness, resizing of the skin graft, and patient satisfaction with cosmetic results.
METHODS: The randomized half of the skin graft was treated with the fractional CO2 -laser two times in a 4-week interval, whereby the first laser treatment was conducted 3-8 weeks after surgery. Two independent dermatologists assessed the adaptation of the treated area and the untreated control of the skin graft to the surrounding skin using follow-up pictures and an 11-point scale (0 representing no adaptation at all and 10 complete adaptation).
RESULTS: Adaptation to the surrounding skin was significantly improved after laser therapy. The mean investigator ratings showed poor adaptation to the surrounding skin before the first treatment (treatment: 2.24 ± 1.00; control group: 1.95 ± 1.27; P < .001; n = 26) but significant improvement at the follow-up visits (8 weeks: treatment: 6.38 ± 1.47; control group 5.29 ± 1.27; P < .001; 6 months: treatment: 7.31 ± 1.24; control group 6.04 ± 0.91; 12 months: treatment: 7.6 ± 1.26; control group: 6.57 ± 1.02; n = 26). After fractional ablative laser treatment, appearance of the skin grafts was significantly improved for all time points. Profilometric analysis showed significantly reduced skin roughness 1 year after laser treatment compared to control (P = .003). Pigmentary irregularities were improved. Melanin distribution was significantly more uniform 1 year after laser treatment compared to control (P = .034). Patients were reasonably satisfied with both sides of the skin graft before treatment but more satisfied with the laser-treated side at the other time points (P < .001).
CONCLUSIONS: Adaptation of the skin graft to the surrounding skin was significantly improved after ablative fractional skin resurfacing. Skin roughness and melanin variation were also improved. Patient satisfaction with the appearance of the skin graft was significantly higher after graft resurfacing. Thus, this treatment modality can be recommended for patients wishing to improve the appearance of their skin graft. Lasers Surg. Med. 50:1010-1016, 2018.
© 2018 Wiley Periodicals, Inc. © 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Ablative fractional laser resurfacing; cosmetic outcome; scar; scar reduction; skin graft

Mesh:

Substances:

Year:  2018        PMID: 29911321     DOI: 10.1002/lsm.22950

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  3 in total

Review 1.  Use of Biologic Agents for Lip and Cheek Reconstruction.

Authors:  Monal Depani; Andrew M Ferry; Andrew E Grush; Tanir A Moreno; Lloyd M Jones; James F Thornton
Journal:  Semin Plast Surg       Date:  2021-12-31       Impact factor: 2.195

2.  Efficacy and safety of a dual-scan protocol for carbon dioxide laser in the treatment of split-thickness skin graft contraction in a red Duroc pig model.

Authors:  Jie Li; Sally Kiu-Huen Ng; Wenjing Xi; Zheng Zhang; Xiaodian Wang; Hua Li; Weijie Su; Jingyan Wang; Yixin Zhang
Journal:  Burns Trauma       Date:  2021-12-31

3.  Fractional CO2 laser to improve noticeable scars after skin cancer surgery: An appraisal by the patients, laypersons, and experts.

Authors:  Nina Wyss; Nicole Graf; Juerg Hafner; Laurence Imhof
Journal:  Dermatol Ther       Date:  2021-05-31       Impact factor: 2.851

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.